[1]刘莹,李泽鹏,周晓玲,等.茯苓四逆汤加减治疗中晚期肝癌临床观察[J].西部中医药,2022,35(04):110-113.[doi:10.12174/j.issn.2096-9600.2022.04.25]
　LIU Ying,LI Zepeng,ZHOU Xiaoling,et al.Clinical Observation on Modified Fuling Sini Decoction in the Treatment of Advanced Hepatocellular Carcinoma[J].Western Journal of Traditional Chinese Medicine,2022,35(04):110-113.[doi:10.12174/j.issn.2096-9600.2022.04.25]
点击复制

茯苓四逆汤加减治疗中晚期肝癌临床观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年04期
页码:
110-113
栏目:
出版日期:
2022-04-15

文章信息/Info

Title:
Clinical Observation on Modified Fuling Sini Decoction in the Treatment of Advanced Hepatocellular Carcinoma
作者:
刘莹1, 李泽鹏1,2, 周晓玲1, 陈峭1, 李灿1, 余静芳1, 宋征福1, 宁碧泉1, 朱昱豪1, 张悦1, 韦宛华1
1.广西柳州市中医医院,广西 柳州 545000
2.广州中医药大学
Author(s):
LIU Ying1, LI Zepeng1,2, ZHOU Xiaoling1, CHEN Qiao1, LI Can1, YU Jingfang1, SONG Zhengfu1, NING Biquan1, ZHU Yuhao1, ZHANG Yue1, WEI Wanhua1
1.Liuzhou City Hospital of Traditional Chinese Medicine, Liuzhou 545000, China
2.Guangzhou University of Chinese Medicine
关键词:
肝癌; 茯苓四逆汤; 温阳化气法; 回顾性研究; 临床研究
Keywords:
hepatocellular carcinoma; decoction; -warming -transforming method; retrospective study; clinical study
分类号:
R735
DOI:
10.12174/j.issn.2096-9600.2022.04.25
文献标志码:
B
摘要:
目的从茯苓四逆汤加减治疗中晚期肝癌出发，探讨温阳化气法治疗中晚期肝癌的辨证诊疗思路并观察临床疗效。 方法选择中晚期原发性肝癌患者126例，采用回顾性分析的方法，按照纳排标准选择后以患者接受的治疗方式进行分组，分为介入组［（单纯肝动脉化疗栓塞（transarterial chemoembolization，TACE）］治疗）51例、中药组（单纯中药治疗）33例和联合组（中药联合TACE治疗）42例。评价3组临床疗效、肝功能指标、凝血酶原时间及T淋巴细胞亚群水平。 结果基于mRECIST标准的疗效评价，介入组和联合治疗组疗效明显优于中药组，且有更高的客观缓解率（P＜0.05）；肝功能指标、凝血酶原时间、T淋巴细胞亚群指标，治疗后联合组较介入组、中药组呈明显改善（P＜0.05）。 结论基于温阳化气法使用茯苓四逆汤加减治疗中晚期肝癌患者可有效改善其肝功能和免疫状态，然而其抗肿瘤作用的疗效评价需要进一步研究。
Abstract:
ObjectiveTo discuss the diagnosis and treatment based on syndrome differentiation of Yang-warming Qi-transforming method in the treatment of advanced hepatocellular carcinoma, and observe its clinical effects based on treating advanced hepatocellular carcinoma by modified Fuling Sini decoction. MethodsAll 126 patients were selected and grouped by using retrospective analysis according to the inclusion and exclusion standard and therapeutic methods the patients accepted, they were divided into 51 cases in the intervention group (single TACE), 33 cases of the herbal group (only herbs) and 42 cases in the combination group (herbs combined with TACE). To assess clinical effects, the indexes of liver function, prothrombin time and the levels of T lymphocyte subsets in three groups. ResultsOn the foundation of clinical assessment of mRECIST criteria, the intervention group and the combination group were superior to the herbal group in clinical effects notably, with higher objective remission rate (P<0.05); in the comparisons of the indexes of liver function, prothrombin time and the levels of T lymphocyte subsets, the improvements of the combination group were more notable than these of the intervention group and the herbal group after treating (P<0.05). ConclusionThe application of modified Fuling Sini decoction based on Yang-warming Qi-transforming method could effectively improve liver function and immunologic function in advanced hepatocellular carcinoma patients, however, clinical evaluation on its anti-tumor effects needs to be further studied.

相似文献/References:

[1]曹军英.纽曼护理对原发性肝癌介入治疗患者焦虑和生活质量的影响[J].西部中医药,2015,28(04):140.
[2]邹勇,殷子斐,程彬彬,等.世界三大饮品预防肝癌研究进展[J].西部中医药,2018,31(05):131.
　ZOU Yong,YIN Zifei,CHENG Binbin,et al.Research Progress of Three Drinks in the Prevention of Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(04):131.
[3]杨军民,何耀辉,马宝梅.大黄?虫丸联合化疗治疗原发性肝癌35例[J].西部中医药,2018,31(10):83.
　YANG Junmin,HE Yaohui,MA Baomei.DaHuang ZheChong Pills Combined with Chemotherapy in Treating 35 Cases of Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(04):83.
[4]刘玉华,王敏△.微波消融治疗肝癌的围手术期护理[J].西部中医药,2017,30(04):122.
　LIU Yuhua,WANG Min.Perioperative Care for the Patients with Liver Cancer Treated by Microwave Ablation[J].Western Journal of Traditional Chinese Medicine,2017,30(04):122.
[5]陈艳,童金龙,郑勤.团体认知行为疗法对青年肝癌患者心理状况与生活质量的影响[J].西部中医药,2017,30(11):115.
　CHEN Yan,TONG Jinlong,ZHENG Qin.Effects of Group Cognitive-behavioral Therapy on Psychological Status and Quality of Life of Young Patients with Hepatic Carcinoma[J].Western Journal of Traditional Chinese Medicine,2017,30(04):115.
[6]曲骞,吴煜△.吴煜教授疏肝健脾法治疗肝癌经验探析[J].西部中医药,2018,31(06):40.
　QU Qian,WU Yu.Analysis of Professor Wu Yu′s Experience of Treating Liver Cancer by Liver-soothing Spleen-invigorating Method[J].Western Journal of Traditional Chinese Medicine,2018,31(04):40.
[7]赵阳.紫草素对荷肝癌大鼠免疫功能的影响[J].西部中医药,2018,31(09):26.
　ZHAO Yang.Effects of Shikonin on Immunologic Function of the Rats Suffering Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(04):26.
[8]林泳欣,王昌俊△.健脾化瘀方对肝癌HepG-2细胞生理活性的影响[J].西部中医药,2018,31(11):11.
　LIN Yongxin,WANG Changjun.Effects of Spleen-invigorating Stasis-eliminating Prescription on Physiological Activity of HepG-2 Cells in Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(04):11.
[9]黄常江,刘俊波,廖天华,等.止痛膏联合三阶梯止痛原则治疗肝癌疼痛60例临床观察[J].西部中医药,2018,31(12):98.
　HUANG Changjiang,LIU Junbo,LIAO Tianhua,et al.Clinical Observation on Pain-relieving Ointment and Three-step Pain-relieving Principles in Treating 60 Cases of Liver Cancer Pain[J].Western Journal of Traditional Chinese Medicine,2018,31(04):98.
[10]谭松,侯爱画,于春凤,等.愈肝散结颗粒对晚期肝癌患者血清VEGF及HIF-1α的影响[J].西部中医药,2019,32(01):5.
　TAN Song,HOU Aihua,YU Chunfeng,et al.Effects of YuGan SanJie Granules on the Expression of VEGF and HIF-1α of the Patients Suffering Advanced Hepatoma[J].Western Journal of Traditional Chinese Medicine,2019,32(04):5.

备注/Memo

备注/Memo:
刘莹（1989—），女，硕士学位，主治医师。研究方向：肝病的中西医结合防治与研究。柳州市科技计划项目（2018AF10503）。
更新日期/Last Update: 2022-06-24